(Q83204245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Jose M Ruiz-Moreno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Javier A Montero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pedro Amat-Peral

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

14 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

595-599

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234588%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00417-010-1599-z

20 January 2020

exact match

0 references

cites work

Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes.

1 reference

12 December 2020

Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization

1 reference

12 December 2020

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

1 reference

12 December 2020

Foveal translocation surgery and myopic subfoveal CNV membrane

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization

1 reference

12 December 2020

A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

12 December 2020

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia

1 reference

12 December 2020

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

1 reference

12 December 2020

Subretinal surgery for choroidal neovascularization in patients with high myopia

1 reference

12 December 2020

Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment

1 reference

12 December 2020

Etiology of choroidal neovascularization in young patients

1 reference

12 December 2020

Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization

1 reference

12 December 2020

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study

1 reference

12 December 2020

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study

1 reference

12 December 2020

Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab

1 reference

12 December 2020

SHORT-TERM EFFICACY AND SAFETY OF INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

1 reference

12 December 2020

Optical coherence tomography to monitor photodynamic therapy in pathological myopia

1 reference

12 December 2020

Intravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-up

1 reference

12 December 2020

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results

1 reference

12 December 2020

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia

1 reference

12 December 2020

Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results

1 reference

12 December 2020

Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes

1 reference

12 December 2020

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia

1 reference

12 December 2020